FDA Calendar for Theratechnologies Inc. (THTCF)

| Register (free)
Theratechnologies Inc. (Theratechnologies) is a Canada-based biopharmaceutical company that discovers or acquires therapeutic products for development and commercialization targeting unmet medical needs. The Company’s advanced compound, tesamorelin, is an analogue of the growth hormone releasing factor. During the fiscal year ended November 30, 2008 (fiscal 2008), it completed a confirmatory Phase III clinical trial evaluating tesamorelin in human immunodeficiency virus (HIV)-associated lipodystrophy, a serious metabolic disorder involving excess abdominal fat.

Around The Net


Drug Pipeline

Drug NameType Of DrugFDA StatusDrug Phase
Tesamorelin Weight Loss Pending DecisionNDA


Events

No future events listed at this time, please check back later.
2 past event(s) found. Click here to view them.

Add New Event

In order to write a comment you must first login.

Login or Register (for free!)

Add Event

$0.00
0
1/1/0001 12:00:00 AM

Sponsors

Other Links